Latest article
Replace on the design of a Section III Precision Medication trial with the Diabetes...
STOCKHOLM, March 4, 2021 / PRNewswire / -
The upcoming phase III study with Diamyd® in emerging type 1 diabetes is based on the first...
Insulin monotherapy ‘suboptimal’ for kind 2 diabetes
medwireNews: Real study results suggest that people with type 2 diabetes who...
Pedal Your Approach To Digital Health With The Cru TV Bike
The pandemic has caused...